$ROIV
Roivant Sciences Ltd.

2021 Q4 Form 10-Q Financial Statement

#000119312522039433 Filed on February 14, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $24.34M $13.99M $5.750M
YoY Change 323.32% 957.22%
Cost Of Revenue $1.384M $6.381M $684.0K
YoY Change 102.34% 792.45%
Gross Profit $22.96M $7.606M $5.066M
YoY Change 353.16% 1150.99%
Gross Profit Margin 94.31% 54.38% 88.1%
Selling, General & Admin $115.5M $437.8M $61.88M
YoY Change 86.72% 632.8%
% of Gross Profit 503.25% 5755.67% 1221.38%
Research & Development $153.5M $254.3M $202.3M
YoY Change -24.13% 161.02%
% of Gross Profit 668.42% 3342.87% 3992.5%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $269.0M $692.0M $264.1M
YoY Change 1.83% 340.37%
Operating Profit -$246.0M -$684.4M -$259.1M
YoY Change -5.04% 337.22%
Interest Expense -$39.47M $474.5M -$18.81M
YoY Change 109.81% 463.13%
% of Operating Profit
Other Income/Expense, Net -$20.55M -$15.35M $2.062M
YoY Change -1096.75% 63.93%
Pretax Income -$306.0M -$225.2M -$275.8M
YoY Change 10.96% 326.69%
Income Tax $38.00K $401.0K -$224.0K
% Of Pretax Income
Net Earnings -$306.1M -$225.6M -$275.6M
YoY Change 11.06% 321.77%
Net Earnings / Revenue -1257.49% -1613.21% -4792.99%
Basic Earnings Per Share -$0.41 -$0.32
Diluted Earnings Per Share -$414.4K -$320.6K -$414.5K
COMMON SHARES
Basic Shares Outstanding 686.6M 650.2M
Diluted Shares Outstanding 686.6M 650.2M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.214B $2.497B $1.696M
YoY Change 130421.43% 13774472.53%
Cash & Equivalents $2.214B $2.497B
Short-Term Investments
Other Short-Term Assets $61.70M $46.11M $281.0K
YoY Change 21860.35% 288075.0%
Inventory
Prepaid Expenses
Receivables $8.921M $9.814M
Other Receivables $2.627M $2.502M
Total Short-Term Assets $2.288B $2.556B $1.977M
YoY Change 115580.37% 7488191.83%
LONG-TERM ASSETS
Property, Plant & Equipment $83.29M $80.10M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $398.7M $436.8M $410.8M
YoY Change -2.94%
Other Assets $29.81M $30.27M $0.00
YoY Change 5974.78%
Total Long-Term Assets $511.8M $547.2M $410.8M
YoY Change 24.6% 109705.94%
TOTAL ASSETS
Total Short-Term Assets $2.288B $2.556B $1.977M
Total Long-Term Assets $511.8M $547.2M $410.8M
Total Assets $2.799B $3.103B $412.8M
YoY Change 578.17% 582692.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.36M $77.16M $207.0K
YoY Change 11665.44% 234994.45%
Accrued Expenses $123.9M $115.6M $14.70M
YoY Change 742.76% 33394.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $160.7M $303.4M $14.93M
YoY Change 976.6% 52395.33%
LONG-TERM LIABILITIES
Long-Term Debt $204.0M $199.9M $0.00
YoY Change
Other Long-Term Liabilities $164.9M $148.7M $49.10M
YoY Change 235.8%
Total Long-Term Liabilities $368.9M $348.6M $49.10M
YoY Change 651.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $160.7M $303.4M $14.93M
Total Long-Term Liabilities $368.9M $348.6M $49.10M
Total Liabilities $933.7M $1.065B $64.03M
YoY Change 1358.26% 184124.45%
SHAREHOLDERS EQUITY
Retained Earnings -$2.209B
YoY Change
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.866B $2.038B $348.8M
YoY Change
Total Liabilities & Shareholders Equity $2.799B $3.103B $412.8M
YoY Change 578.17% 582692.91%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$306.1M -$225.6M -$275.6M
YoY Change 11.06% 321.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$268.5M -$120.6M -$236.9M
YoY Change 13.36% 23.0%
INVESTING ACTIVITIES
Capital Expenditures -$6.073M -$2.761M -$107.0K
YoY Change 5575.7% 111.9%
Acquisitions
YoY Change
Other Investing Activities $0.00 $320.2M $0.00
YoY Change -57171.3%
Cash From Investing Activities -$6.073M $317.4M -$107.0K
YoY Change 5575.7% -17128.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.422M 303.9M 464.0K
YoY Change -1915.09% 72.73%
NET CHANGE
Cash From Operating Activities -268.5M -120.6M -236.9M
Cash From Investing Activities -6.073M 317.4M -107.0K
Cash From Financing Activities -8.422M 303.9M 464.0K
Net Change In Cash -283.0M 500.7M -236.5M
YoY Change 19.66% 558.47%
FREE CASH FLOW
Cash From Operating Activities -$268.5M -$120.6M -$236.9M
Capital Expenditures -$6.073M -$2.761M -$107.0K
Free Cash Flow -$262.4M -$117.8M -$236.8M
YoY Change 10.84% 21.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
Roivant Sciences Ltd.
dei Entity Central Index Key
EntityCentralIndexKey
0001635088
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00000003
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00000003
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.87
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
686589478
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
629668846
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
662268788
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
629076726
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2414357000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2039514000
CY2021Q2 roiv Issuance Of Subsidiary Warrants
IssuanceOfSubsidiaryWarrants
2075000
CY2021Q2 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19269000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2439000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-101078000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1957341000
CY2021Q3 roiv Stock Issued During Period Value Common Shares Upon Closing Of Business Combination And Pipe Financing
StockIssuedDuringPeriodValueCommonSharesUponClosingOfBusinessCombinationAndPipeFinancing
129097000
CY2021Q3 roiv Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration
StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration
0
CY2021Q3 roiv Stock Issued During Period Value Subsidiary Preferred Shares
StockIssuedDuringPeriodValueSubsidiaryPreferredShares
70000000
CY2021Q3 roiv Stock Issued During Period Value Subsidiary Common And Preferred Shares To The Company
StockIssuedDuringPeriodValueSubsidiaryCommonAndPreferredSharesToTheCompany
0
CY2021Q3 roiv Adjustments Of Payment Of Subscription Receivable Value Equity Component
AdjustmentsOfPaymentOfSubscriptionReceivableValueEquityComponent
100000000
CY2021Q3 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
397312000
CY2021Q3 roiv Repurchase Of Equity Awards
RepurchaseOfEquityAwards
2247000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2545000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-225640000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2428408000
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
56116000
CY2021Q4 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
71216000
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2393000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-306085000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2247262000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2086204000
CY2020Q2 roiv Issuance Of Subsidiary Common Shares Net Value
IssuanceOfSubsidiaryCommonSharesNetValue
181180000
CY2020Q2 roiv Issuance Of Subsidiary Common Shares To The Company Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyValue
0
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
63000
CY2020Q2 roiv Deconsolidation Of Subsidiary
DeconsolidationOfSubsidiary
-3054000
CY2020Q2 roiv Repurchase Of Equity Awards
RepurchaseOfEquityAwards
113000
CY2020Q2 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14278000
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-820000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-7977000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2269761000
CY2020Q3 roiv Issuance Of Subsidiary Common Shares Net Value
IssuanceOfSubsidiaryCommonSharesNetValue
175917000
CY2020Q3 roiv Issuance Of Subsidiary Common Shares To The Company Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyValue
0
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
119000
CY2020Q3 roiv Consolidation Of Unconsolidated Entity
ConsolidationOfUnconsolidatedEntity
9178000
CY2020Q3 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2020Q3 roiv Adjustments Due To Transfer From To Noncontrolling Interest Value
AdjustmentsDueToTransferFromToNoncontrollingInterestValue
0
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13914000
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1034000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-53498000
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000000
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
725000
CY2020Q4 roiv Adjustments Due To Transfer From To Noncontrolling Interest Value
AdjustmentsDueToTransferFromToNoncontrollingInterestValue
0
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17324000
CY2020Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5541000
CY2020Q4 us-gaap Profit Loss
ProfitLoss
-275597000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2171268000

Files In Submission

Name View Source Status
0001193125-22-039433-index-headers.html Edgar Link pending
0001193125-22-039433-index.html Edgar Link pending
0001193125-22-039433.txt Edgar Link pending
0001193125-22-039433-xbrl.zip Edgar Link pending
d12341d10q.htm Edgar Link pending
d12341d10q_htm.xml Edgar Link completed
d12341dex101.htm Edgar Link pending
d12341dex311.htm Edgar Link pending
d12341dex312.htm Edgar Link pending
d12341dex321.htm Edgar Link pending
d12341dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roiv-20211231.xsd Edgar Link pending
roiv-20211231_cal.xml Edgar Link unprocessable
roiv-20211231_def.xml Edgar Link unprocessable
roiv-20211231_lab.xml Edgar Link unprocessable
roiv-20211231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending